A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant
- Status
- WITHDRAWN
- Phase
- PHASE4
Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C
- Status
- UNKNOWN
- Phase
- PHASE4
Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063)
- Status
- TERMINATED
- Phase
- PHASE3
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
- Status
- COMPLETED
- Phase
- PHASE2